AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2021
Jun 2, 2021
34395_dirs_2021-06-02_c385cb82-3e93-47d0-b333-6f5b6cd6a428.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-05-28
Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-28 | Common Stock | S | 10000 | $3.54 | Disposed | 24949 | Direct |
More from VOLITIONRX LTD
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13
Annual Report
2026
Apr 30